Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG)
Melissa T. Carter(University of Ottawa), Hilary Vallance(University of British Columbia), Daniela Buhaş(McGill University Health Centre), Myriam Srour(McGill University), Alison Eaton(University of Alberta), Heather Howley(Agricultural Research Institute of Ontario), Sarah Dyack(Dalhousie University), Tanya N. Nelson(University of British Columbia), Michal Inbar‐Feigenberg(University of Toronto), Ping-Yee Billie Au(Alberta Children's Hospital), M. Elizabeth McCready(Health Sciences Centre), M. E. Suzanne Lewis(University of British Columbia), Anne Kawamura(Holland Bloorview Kids Rehabilitation Hospital)
Cited by 57
Related Papers
Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test
|Genetics in Medicine|2017|563
Whole-genome sequencing of quartet families with autism spectrum disorder
|Nature Medicine|2015|540
Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing
|The American Journal of Human Genetics|2013|496
Whole-genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine
|npj Genomic Medicine|2016|377